Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: Effects of apolipoprotein E deficiency and probucol or phytosterol treatment

Metabolism: Clinical and Experimental

Volumn 50, Issue 6, 2001, Pages 708-714

  Moghadasian, M H ^a,b   Nguyen, L B ^a,b   Shefer, S ^a,b   Salen, G ^a,b   Batta, A K ^a,b   Frohlich, J J ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; BILE ACID; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PHYTOSTEROL; PROBUCOL; STEROL; STEROL 27 HYDROXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; BILE ACID SYNTHESIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CHOLESTEROL METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG BINDING SITE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG FECES LEVEL; DRUG LIVER LEVEL; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; EXPERIMENTAL MODEL; GENE DELETION; HYPERLIPOPROTEINEMIA TYPE 3; LIPID ABSORPTION; LIVER MEMBRANE; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; STIMULATION;

EID: 0034966879     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.23303     Document Type: Article

References (30)

1. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
2. Lipoprotein receptors and cholesterol homeostasis
3. Type III hyperlipoproteinemia associated with apolipoprotein E deficiency
4. Characterization of a unique human apolipoprotein E variant associated with type III hyperlipoproteinemia
5. The biochemical, clinical and genetic features of type III hyperlipoproteinemia
6. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
7. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
8. Pro-atherogenic and anti-atherogenic effects of probucol and phytosterols in apo E-deficient mice: Possible mechanisms of action
9. Tall oil"-derived phytosterols reduce atherosclerosis in apo E-deficient mice
10. Prevention of atherosclerosis by phytosterols in transgenic mice
11. Apo E-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum
12. Effects of the antioxidant N, N′-diphenyl 1, 4-phenylenediamine (DPPD) on atherosclerosis in apo E-deficient mice
13. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice
14. Identification of 8-dehydrocholesterol (cholesta-5, 8-dien-3 beta-ol) in patients with Smith-Leli-Opitz syndrome
15. The effect of increased hepatic sitosterol on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and cholesterol 7 alpha-hydroxylase in the rat and sitosterolemic homozygotes
16. Competitive inhibition of hepatic sterol 27-hydroxylase by sitosterol: Decreased activity in sitosterolemia
17. Competitive inhibition of bile acid synthesis by endogenous cholesterol and sitosterol in sitosterolemia with xanthomatosis
18. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells
19. Increased binding of low-density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol
20. Unexpected inhibition of cholesterol 7alpha-hydroxylase by cholesterol in New Zealand white and Watanabe heritable hyperlipidemic rabbits
21. An overview of the biochemical pharmacology of probucol
22. Studies on the mechanism of action of probucol
23. Mode of action of probucol in reducing serum cholesterol in mice
24. Mechanisms of action of plant sterols on inhibition of cholesterol absorption: Comparison of sitosterol and sitostanol
25. Inhibition of cholesterol absorption in rats by plant sterols
26. Discrimination between cholesterol and sitosterol for absorption in rats
27. Increasing hepatic cholesterol 7alpha-hydroxylase reduces plasma cholesterol concentrations in normocholesterolemic and hypercholesterolemic rabbits
28. Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver
29. Regulatory effects of sterols and bile acids on hepatic 3-hydroxy-3-methylglutaryl CoA reductase and cholesterol 7alpha-hydroxylase in the rat
30. Unexpected failure of bile acid malabsorption to stimulate cholesterol synthesis in sitosterolemia with xanthomatosis. Comparison with lovastatin